Cladis Investment Advisory’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Hold
3,500
0.14% 137
2025
Q4
$276K Hold
3,500
0.15% 129
2025
Q3
$288K Hold
3,500
0.17% 121
2025
Q2
$281K Hold
3,500
0.18% 116
2025
Q1
$281K Hold
3,500
0.2% 106
2024
Q4
$287K Hold
3,500
0.2% 101
2024
Q3
$289K Hold
3,500
0.2% 104
2024
Q2
$246K Hold
3,500
0.18% 115
2024
Q1
$259K Hold
3,500
0.19% 115
2023
Q4
$231K Hold
3,500
0.18% 116
2023
Q3
$220K Buy
+3,500
New +$218K 0.19% 114
2023
Q2
Sell
-3,500
Closed -$203K 142
2023
Q1
$203K Hold
3,500
0.18% 129
2022
Q4
$253K Hold
3,500
0.25% 107
2022
Q3
$213K Hold
3,500
0.23% 113
2022
Q2
$220K Hold
3,500
0.22% 116
2022
Q1
$246K Hold
3,500
0.2% 127
2021
Q4
$219K Buy
+3,500
New +$220K 0.18% 135

Other funds holding MET

Cladis Investment Advisory's MET Position: Q1 2026 in Review

Cladis Investment Advisory held its MetLife (MET) position steady in Q1 2026 at 3,500 shares worth $248K. The position accounts for 0.14% of the portfolio, ranked #137.

Cladis Investment Advisory first reported a position in MET in Q4 2021 and has held it in 17 quarters since. The position peaked at $289K in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Cladis Investment Advisory held 3,500 shares of MetLife worth $248K as of Q1 2026.
  • Cladis Investment Advisory left its MetLife share count unchanged in Q1 2026.
  • MetLife made up 0.14% of Cladis Investment Advisory's portfolio in Q1 2026, its #137 holding.
  • Cladis Investment Advisory first reported a position in MetLife in Q4 2021 and has held it in 17 quarters since.
  • Cladis Investment Advisory's MetLife position peaked at $289K in Q3 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Cladis Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.